Seppi Lin is currently the Vice President and Head of OMNI Early Clinical Development at Genentech, a position held since 2020. Previously, Seppi has held various roles in the pharmaceutical industry, including Director at Gilead and Senior Medical Director at AbbVie. Seppi's extensive experience also includes positions at Amgen and StemCells, Inc., as well as a consultancy role at Stemcentrx, Inc. Seppi completed a Doctor of Medicine (MD) degree at UCSF and earned a Bachelor of Science in Biology from Stanford University.
This person is not in any teams
This person is not in any offices